Airbus, Rolls to brief airlines as pressure for A350 checks eases [Yahoo! Finance Canada]
Olema Pharmaceuticals, Inc. (OLMA)
Company Research
Source: Yahoo! Finance Canada
By Tim Hepher PARIS (Reuters) - Airlines will likely be told there is no immediate need for global checks on the Airbus A350-1000, ending days of uncertainty after an engine emergency prompted Cathay Pacific to review its fleet, two people familiar with the matter said. Barring last-minute changes as investigators examine parts from an A350 that returned to base on Monday, Airbus and engine maker Rolls-Royce are expected to move to allay wider safety concerns in their first briefings to carriers on Thursday. Airbus declined comment and referred queries to Hong Kong investigators, who could not be reached. Rolls-Royce and Cathay Pacific did not immediately respond to requests for comment. Although the stance suggests the incident is increasingly being seen as isolated, it is too early to rule out further findings or analysis that may eventually require action by other airlines, the people said, asking not to be identified. A final decision rests with regulators. It was not i
Show less
Read more
Impact Snapshot
Event Time:
OLMA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OLMA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OLMA alerts
High impacting Olema Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
OLMA
News
- Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswire
- Olema Oncology to Participate in Morgan Stanley 22nd Annual Global Healthcare ConferenceGlobeNewswire
- Olema Pharmaceuticals, Inc. (NASDAQ: OLMA) had its price target lowered by analysts at JPMorgan Chase & Co. from $33.00 to $31.00. They now have an "overweight" rating on the stock.MarketBeat
- Olema Pharmaceuticals, Inc. (NASDAQ: OLMA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.MarketBeat
- Olema Pharmaceuticals, Inc. (NASDAQ: OLMA) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $30.00 price target on the stock.MarketBeat
OLMA
Earnings
- 3/11/24 - In-Line
OLMA
Sec Filings
- 9/27/24 - Form 8-K
- 8/6/24 - Form 10-Q
- 8/6/24 - Form 8-K
- OLMA's page on the SEC website